Zobrazeno 1 - 10
of 4 594
pro vyhledávání: '"Kh, Park"'
Autor:
SH Cho, Ha Kim, YS Jung, MH Hur, WC Noh, Hyeoung-Joon Kim, SS Kang, SH Han, SH Ahn, Sy Kim, Sa Im, BW Park, ES Lee, KH Park, MH Lee, W Han, SJ Nam, S-H Lee, J Jung, JH Yoon
Publikováno v:
Cancer Research. 79:P4-14
BACKGROUND Assessment of restoration of ovarian function after chemotherapy is critical with respect to the initiation of different types of endocrine treatment in young high risk breast cancer patients METHODS In total, 1289 women who remained preme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b96d16f4ecf505d1d988f610e2ee2ae1
https://doi.org/10.1158/1538-7445.sabcs18-p4-14-04
https://doi.org/10.1158/1538-7445.sabcs18-p4-14-04
Autor:
Jungsil Ro, J-H Ahn, KS Lee, S-B Kim, K-H Lee, In Hae Park, KH Park, Y.S. Chae, Young-Ae Park, Sung Hoon Sim, S Lee, Jung Ho Sohn, KH Jung, Y-H Im, Hj. Kim, B-H Nam, S-A Im, Y. Kim
Publikováno v:
Cancer Research. 79:P6-17
Background The continuum of anti-HER2 agents is regarded as a standard strategy for HER2 positive metastatic breast cancer patients who had progressed disease with anti-HER2 agent- containing treatments. However, there has been lack of data on which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf4aabac4316b9f75d1bd7ab4af85c5c
https://doi.org/10.1158/1538-7445.sabcs18-p6-17-23
https://doi.org/10.1158/1538-7445.sabcs18-p6-17-23
Autor:
KH Park, Young-Ae Park, J-Y Kim, S Lee, JS Ahn, Jong Han Yu, W. Park, Y-H Im, Je Lee, SW Kim, SJ Nam
Publikováno v:
Cancer Research. 79:P1-09
Introduction: Genetic alteration of Estrogen Receptor 1(ESR1) gene have been associated with acquired endocrine resistance and occurred in about 20% of endocrine resistant estrogen receptor(ER)-positive metastatic breast cancer(MBC). Mutations in lig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::006a7deeeaed23fda025f91245005213
https://doi.org/10.1158/1538-7445.sabcs18-p1-09-11
https://doi.org/10.1158/1538-7445.sabcs18-p1-09-11
Autor:
T-Y Kim, K.H. Lee, J-H Ahn, J.H. Kim, KH Park, S-A Im, Young-Ae Park, KH Jung, IH Park, S-B Kim, Hye-Suk Han, K-H Lee, SH Sohn, KS Lee, Songhui Kim, Y.S. Chae, Eui Jin Lee, Y-H Im, J-Y Kim, S.J. Lee, Gun Min Kim
Publikováno v:
Cancer Research. 79:P3-11
Introduction : A phase II, multicenter, randomized clinical trial of the comparison between eribulin plus gemcitabine (EG) and paclitaxel plus gemcitabine (PG) as first-line chemotherapy for patients with human epidermal growth factor receptor 2 (HER
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9377cc23cea3f3b6f01cabde683c570
https://doi.org/10.1158/1538-7445.sabcs18-p3-11-07
https://doi.org/10.1158/1538-7445.sabcs18-p3-11-07
Publikováno v:
Can J Vet Res
Scopus-Elsevier
Europe PubMed Central
Scopus-Elsevier
Europe PubMed Central
The objective of this study was to compare the virulence of 3 major Korean porcine circovirus type 2 (PCV2) genotypes in terms of clinical signs, PCV2 viremia and antibody titers, lymphoid lesions, and PCV2-antigen within lymphoid lesions in experime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::2bb09997a80ba2ee97abb00e636ef6da
https://europepmc.org/articles/PMC7301680/
https://europepmc.org/articles/PMC7301680/
Publikováno v:
Planta Medica. 81:S1-S381
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3680449fea6e79d97d1bb8519c15c43e
https://doi.org/10.1055/s-0036-1597063
https://doi.org/10.1055/s-0036-1597063
Publikováno v:
Cancer Research. 78:P6-08
Background: Anthracycline (AC) and/or trastuzumab (T) are the most commonly used for neo-/adjuvant therapy for early breast cancer. However, use of those regimens are limited owing to congestive heart failure (CHF). Although reported incidence from p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::71a03d6c52701c31a754415be929774c
https://doi.org/10.1158/1538-7445.sabcs17-p6-08-09
https://doi.org/10.1158/1538-7445.sabcs17-p6-08-09
Autor:
G.M. Kim, Y.S. Chae, K.H. Lee, J-H Ahn, Y-H Im, T-Y Kim, Jae Ho Jeong, Young-Ae Park, Se Lee, KS Lee, S-J Koh, KH Park, Ke Lee, J.H. Kim, S-A Im, EK Cho, JH Yoon, Jung Ho Sohn, HS Won, KH Jung
Publikováno v:
Cancer Research. 76:P1-09
Background Endocrine therapy (E) has a major role in treatment of hormone receptor (HR)-positive metastatic breast cancer (MBC). However, in contrast to western countries, premenopausal patients (PRE) more prevalent (50% of all breast cancer patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::80a0d7f60ae44c4ebd41d10b1324f025
https://doi.org/10.1158/1538-7445.sabcs15-p1-09-09
https://doi.org/10.1158/1538-7445.sabcs15-p1-09-09
Autor:
T-Y Kim, S-B Kim, Young-Ae Park, KS Lee, JH Yoon, Jae Ho Jeong, J.H. Kim, KH Jung, S-A Im, K.H. Lee, S-J Koh, EK Cho, KH Park, Y-H Im, Jung Ho Sohn, HS Won, Y.S. Chae, G.M. Kim, Se Lee, Ke Lee
Publikováno v:
Cancer Research. 76:P6-10
Background Recently, many clinical trials (TRIAL) especially incorporated with molecular-targeted agents are being conducted in treatment for breast cancer worldwide. However, the relation of participating clinical trials with survival has not been a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01454d8c622874b1de04283909fb3285
https://doi.org/10.1158/1538-7445.sabcs15-p6-10-03
https://doi.org/10.1158/1538-7445.sabcs15-p6-10-03
Publikováno v:
Cancer Research. 77:P2-04
Background Recently, the balance in immune system between immune surveillance and tolerance is known to be associated with the prognosis of breast cancer patients. The aim of this study was to investigate changes of tumor-infiltrating lymphocytes (TI
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4494aef4cfb577a5d7468b97dfa57f6b
https://doi.org/10.1158/1538-7445.sabcs16-p2-04-24
https://doi.org/10.1158/1538-7445.sabcs16-p2-04-24